Acetylation of p53 Inhibits Its Ubiquitination by Mdm2
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In response to DNA damage, the activity of the p53 tumor suppressor is modulated by protein stabilization and post-translational modifications including acetylation. Interestingly, both acetylation and ubiquitination can modify the same lysine residues at the C terminus of p53, implicating a role of acetylation in the regulation of p53 stability. However, the direct effect of acetylation on Mdm2-mediated ubiquitination of p53 is still lacking because of technical difficulties. Here, we have developed a method to obtain pure acetylated p53 proteins from cells, and by using an in vitro purified system, we provide the direct evidence that acetylation of the C-terminal domain is sufficient to abrogate its ubiquitination by Mdm2. Importantly, even in the absence of DNA damage, acetylation of the p53 protein is capable of reducing the ubiquitination levels and extending its half-life in vivo. Moreover, we also show that acetylation of p53 can affect its ubiquitination through other mechanisms in addition to the site competition. This study has significant implications regarding a general mechanism by which protein acetylation modulates ubiquitination-dependent proteasome proteolysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon DNA damage, p53 becomes acetylated at multiple residues within its C-terminal domain to stabilize the protein via directly blocking ubiquitination at acetylated sites as well as hindering the interaction between p53 and MDM2 to discourage ubiquitination at unacetylated sites [47,48].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [48]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Self-citationThe HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Research works printed but not linked: 1
- Appella, 2000, Pathol. Biol. (Paris), 48, 227
Cited by
Items 101–200 of 520
Zhang, Q., Zeng, S. X., Zhang, Y., Zhang, Y., Ding, D., Ye, Q., Meroueh, S. O., & Lu, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100211 · Cited by 109
Genetic and epigenetic determinants of diffuse large B-cell lymphoma
Bakhshi, T. J., & Georgel, P. T. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00389-w · Cited by 121
Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency
Kang, N., Tong, C., Boussouar, F., Baker, D. J., Xu, W., Leontovich, A. A., Taylor, W. R., Brindle, P. K., & van Deursen, J. M. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00022-4 · Cited by 118
Tang, Y.-J., Zhang, Z., Yan, T., Chen, K., Xu, G.-F., Xiong, S., Wu, D.-Q., Chen, J., José, P. A., Zeng, C., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02183-5 · Cited by 113
Huang, W., Smaldino, P. J., Zhang, Q., Miller, L. D., Cao, P. D., Stadelman, K. M., Wan, M., Giri, B., Lei, M., Nagamine, Y., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr849 · Cited by 114
Monte, M., Benetti, R., Buscemi, G., Sandy, P., Sal, G. D., & Schneider, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302902200 · Cited by 114
Gupta, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1449 · Cited by 123
Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA‐1
Hernández‐Hernández, Á., Ray, P., Litos, G., Cirò, M., Ottolenghi, S., Beug, H., & Boyes, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601228 · Cited by 107
Shan, X., Fu, Y.-S., Aziz, F., Wang, X.-Q., Yan, Q., & Liu, J.-W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115401 · Cited by 101
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 109
Kretzner, L., Scuto, A., Dino, P. M., Kowolik, C. M., Wu, J., Ventura, P., Jove, R., Forman, S. J., Yen, Y., & Kirschbaum, M. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2259 · Cited by 101
Lassot, I., Estrabaud, E., Emiliani, S., Benkirane, M., Benarous, R., & Margottin-Goguet, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505294200 · Cited by 99
New insights into p53 activation
Brooks, C. L., & Gu, W. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 102
Self-citationOlmos, Y., Brosens, J. J., & Lam, E. W. ‐. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.001 · Cited by 107
MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
Kruse, J.-P., & Gu, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805658200 · Cited by 100
Self-citationPosttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 105
HIV‐1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses
Col, E., Caron, C., Chable‐Bessia, C., Legube, G., Gazzeri, S., Komatsu, Y., Yoshida, M., Benkirane, M., Trouche, D., & Khochbin, S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600734 · Cited by 96
Post-translational modification networks regulating FOXP3 function
van Loosdregt, J., & Coffer, P. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.005 · Cited by 106
Blanco, S., Klimcakova, L., Vega, F. M., & Lazo, P. A. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05256.x · Cited by 97
CCAAT/Enhancer-binding Protein (C/EBP) β Is Acetylated at Multiple Lysines
Ceseña, T. I., Cardinaux, J., Kwok, R. P. S., & Schwartz, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511451200 · Cited by 110
FOXO1: A Potential Target for Human Diseases
Lu, H., & Huang, H. (2011) · Current Drug Targets · doi:10.2174/138945011796150280 · Cited by 100
Tu, A. W., & Luo, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700085200 · Cited by 92
A new mechanism of RhoA ubiquitination and degradation: Roles of SCF(FBXL19) E3 ligase and Erk2
Wei, J., Mialki, R. K., Dong, S., Khoo, A., Mallampalli, R. K., Zhao, Y., & Zhao, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.07.005 · Cited by 92
Kurki, S., Latonen, L., & Laiho, M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00714 · Cited by 91
Posttranslationale Proteinmodifikation: die Chemie der Proteomdiversifizierung
Walsh, C. T., Garneau‐Tsodikova, S., & Gatto, G. J. J. (2005) · Angewandte Chemie · doi:10.1002/ange.200501023 · Cited by 95
Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., & Iftner, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1307 · Cited by 95
PCAF/GCN5-Mediated Acetylation of RPA1 Promotes Nucleotide Excision Repair
Zhao, M., Geng, R., Guo, X., Yuan, R., Zhou, X., Zhong, Y., Huo, Y., Zhou, M., Shen, Q., Li, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.015 · Cited by 87
Huang, H., Liu, N., Guo, H., Liao, S., Li, X., Yang, C., Liu, S., Song, W., Liu, C., Guan, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049062 · Cited by 97
Zhao, J., Mialki, R. K., Wei, J., Coon, T. A., Zou, C., Chen, B. B., Mallampalli, R. K., & Zhao, Y. (2013) · The FASEB Journal · doi:10.1096/fj.12-223099 · Cited by 82
Asaka, R., Miyamoto, T., Yamada, Y., Ando, H., Mvunta, D. H., Kobara, H., & Shiozawa, T. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.119 · Cited by 96
Mendoza, M., Mandani, G., & Momand, J. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2013-0027 · Cited by 86
Targeting p53-MDM2-MDMX Loop for Cancer Therapy
Zhang, Q., Zeng, S. X., & Lu, H. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_16 · Cited by 83
Xin, H., Wang, M., Tang, W., Shen, Z., Miao, L., Wu, W., Li, C., Wang, X., Xin, X., & Zhu, Y. Z. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6315 · Cited by 90
Acetylation/Deacetylation Modulates the Stability of DNA Replication Licensing Factor Cdt1
Glozak, M. A., & Seto, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809394200 · Cited by 82
Xie, X., Piao, L., Bullock, B. N., Smith, A., Su, T., Zhang, M., Teknos, T. N., Arora, P. S., & Pan, Q. (2013) · Oncogene · doi:10.1038/onc.2013.25 · Cited by 94
Reviving the guardian of the genome: Small molecule activators of p53
Nguyen, D., Liao, W., Zeng, S. X., & Lu, H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.013 · Cited by 79
A predictive coarse-grained model for position-specific effects of post-translational modifications
Perdikari, T. M., Jovic, N., Dignon, G. L., Kim, Y. C., Fawzi, N. L., & Mittal, J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.01.034 · Cited by 80
McCormack, E., Haaland, I., Venås, G., Forthun, R. B., Huseby, S., Gausdal, G., Knappskog, S., Micklem, D., Lorens, J. B., Bruserud, Ø., et al. (2011) · Leukemia · doi:10.1038/leu.2011.315 · Cited by 88
Kim, J. H., Kim, K., Youn, B. U., Jin, H. M., Kim, J.-Y., Moon, J. B., Ko, A., Seo, S.-B., Lee, K.-Y., & Kim, N. (2011) · Biochemical Journal · doi:10.1042/bj20110062 · Cited by 80
The methylproteome and the intracellular methylation network
Erce, M. A., Pang, C. N. I., Hart‐Smith, G., & Wilkins, M. R. (2012) · PROTEOMICS · doi:10.1002/pmic.201100397 · Cited by 88
Acetylation regulates ribonucleotide reductase activity and cancer cell growth
Chen, G., Luo, Y., Warncke, K., Sun, Y., Yu, D. S., Fu, H., Behera, M., Ramalingam, S. S., Doetsch, P. W., Duong, D. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11214-9 · Cited by 82
A global view of the human post-translational modification landscape
Kitamura, N., & Galligan, J. J. (2023) · Biochemical Journal · doi:10.1042/bcj20220251 · Cited by 90
Wilking, M. J., Singh, C. K., Nihal, M., Zhong, W., & Ahmad, N. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.001 · Cited by 85
The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription
Hsu, C.-H., Peng, K.-L., Jhang, H.-C., Lin, C.-H., Wu, S.-Y., Chiang, C.-M., Lee, S.-C., Yu, W., & Juan, L.-J. (2011) · Oncogene · doi:10.1038/onc.2011.415 · Cited by 89
Modulation of Binding of DNA to the C-Terminal Domain of p53 by Acetylation
Friedler, A., Veprintsev, D. B., Freund, S. M. V., von Glos, K. I., & Fersht, A. R. (2005) · Structure · doi:10.1016/j.str.2005.01.020 · Cited by 81
GCN5-dependent acetylation of HIV-1 integrase enhances viral integration
Terreni, M., Valentini, P., Liverani, V., Gutierrez, M. I., Di Primio, C., Di Fenza, A., Tozzini, V., Allouch, A., Albanese, A., Giacca, M., et al. (2010) · Retrovirology · doi:10.1186/1742-4690-7-18 · Cited by 78
Nelson, L. E., Valentine, R. J., Cacicedo, J. M., Gauthier, M.-S., Ido, Y., & Ruderman, N. B. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2011 · Cited by 79
Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification
Banerjee, N. S., Moore, D. W., Broker, T. R., & Chow, L. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801156115 · Cited by 86
Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation
Kulikov, R., Winter, M., & Blattner, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513311200 · Cited by 79
Dou, H., Duan, Y., Zhang, X., Yu, Q., Di, Q., Song, Y., Li, P., & Gong, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009282 · Cited by 82
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 88
Cell and tissue responses to genotoxic stress
Coates, P. J., Lorimore, S. A., & Wright, E. G. (2005) · The Journal of Pathology · doi:10.1002/path.1701 · Cited by 85
MDM2: current research status and prospects of tumor treatment
Yao, Y., Zhang, Q., Li, Z., & Zhang, H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03356-8 · Cited by 82
Barbour, H., Nkwe, N. S., Estavoyer, B., Messmer, C., Gushul-Leclaire, M., Villot, R., Uriarte, M., Boulay, K., Hlayhel, S., Farhat, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106276 · Cited by 80
Haloarchaeal proteases and proteolytic systems
Castro, R. E. D., Maupin-furlow, J. A., Giménez, M. I., Seitz, M. K. H., & Sanchez, J. J. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00003.x · Cited by 79
Role of influenza A virus NP acetylation on viral growth and replication
Giese, S., Ciminski, K., Bolte, H., Moreira, É. A., Lakdawala, S. S., Hu, Z., David, Q., Kolesnikova, L., Götz, V., Zhao, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01112-3 · Cited by 75
Type I phosphatidylinositol-4,5-bisphosphate 4-phosphatase regulates stress-induced apoptosis
Zou, J., Marjanovic, J., Kisseleva, M. V., Wilson, M., & Majerus, P. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708189104 · Cited by 74
Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination
Li, H., Wittwer, T., Weber, A., Schneider, H., Moreno, R., Maine, G. N., Kracht, M., Schmitz, M. L., & Burstein, E. (2012) · Oncogene · doi:10.1038/onc.2011.253 · Cited by 70
Ubiquitination of p53 at Multiple Sites in the DNA-Binding Domain
Chan, W. M., Mak, M. C., Fung, T. K., Lau, A., Siu, W. Y., & Poon, R. Y. C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0097 · Cited by 72
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
Li, Z., Hao, Q., Luo, J., Xiong, J., Zhang, S., Wang, W., Bai, L., Wang, W., Chen, M., Wang, W., et al. (2015) · Oncogene · doi:10.1038/onc.2015.349 · Cited by 79
Self-citationInhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 70
Regulation of E2F-1 after DNA Damage by p300-Mediated Acetylation and Ubiquitination
Galbiati, L., Mendoza-Maldonado, R., Gutiérrez, M. I., & Giacca, M. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1784 · Cited by 93
Chen, X., Wong, J. Y. C., Wong, P. W., & Radany, E. H. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0471 · Cited by 77
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 81
It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
Kung, C.-P., & Weber, J. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.818744 · Cited by 78
Bone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation
Yi, S.-J., Lee, H.-R., Lee, J., Lee, K., Kim, J., Kim, Y., Park, J., & Kim, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133147 · Cited by 75
Coni, S., Antonucci, L., D'Amico, D., Di Magno, L., Infante, P., De Smaele, E., Giannini, G., Di Marcotullio, L., Screpanti, I., Gulino, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065718 · Cited by 68
Acetylation of Drosha on the N-Terminus Inhibits Its Degradation by Ubiquitination
Tang, X., Wen, S., Zheng, D., Tucker, L. D., Cao, L., Pantazatos, D., Moss, S. F., & Ramratnam, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072503 · Cited by 71
Zhang, J., Zhang, C., Cui, J., Ou, J., Han, J., Qin, Y., Zhi, F., & Wang, R. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.149 · Cited by 73
Extensive Post-translational Modification of Active and Inactivated Forms of Endogenous p53
DeHart, C. J., Chahal, J. S., Flint, S. J., & Perlman, D. H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030254 · Cited by 70
Zecha, J., Gabriel, W., Spallek, R., Chang, Y.-C., Mergner, J., Wilhelm, M., Bassermann, F. C., & Küster, B. (2022) · Nature Communications · doi:10.1038/s41467-021-27639-0 · Cited by 73
Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
Nguyen, T.-A., Menendez, D., Resnick, M. A., & Anderson, C. W. (2014) · Human Mutation · doi:10.1002/humu.22506 · Cited by 69
Role of Dietary Antioxidants in p53‐Mediated Cancer Chemoprevention and Tumor Suppression
Merlin, J. P. J., Rupasinghe, H. P. V., Dellaire, G., & Murphy, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9924328 · Cited by 77
Human tumor suppressor p53 and DNA viruses
Collot‐Teixeira, S., Bass, J., Denis, F., & Ranger‐Rogez, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.431 · Cited by 69
hSSB1 regulates both the stability and the transcriptional activity of p53
Xu, S., Wu, Y., Chen, Q., Cao, J., Hu, K., Tang, J., Sang, Y., Lai, F., Wang, L., Zhang, R., et al. (2012) · Cell Research · doi:10.1038/cr.2012.162 · Cited by 69
Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors
Huang, X., Cao, Z., Qian, J., Ding, T., Wu, Y., Zhang, H., Zhong, S., Wang, X., Ren, X., Zhang, W., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01562-5 · Cited by 69
CBP-Mediated FOXO-1 Acetylation Inhibits Pancreatic Tumor Growth by Targeting SirT
Pramanik, K. C., Fofaria, N. M., Gupta, P., & Srivastava, S. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0863 · Cited by 72
Chen, J., Chou, C., Chang, Y.-F., & Chen, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8030 · Cited by 68
An Essential Role of Human Ada3 in p53 Acetylation
Nag, A., Germaniuk-Kurowska, A., Dimri, M., Sassack, M. A., Gurumurthy, C. B., Gao, Q., Dimri, G., Band, H., & Band, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610443200 · Cited by 64
Dong, S., Zhao, J., Wei, J., Bowser, R. K., Khoo, A., Liu, Z., Luketich, J. D., Pennathur, A., Ma, H., & Zhao, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-76 · Cited by 67
Epigenetic regulation of skeletal myogenesis
Saccone, V., & Puri, P. (2010) · Organogenesis · doi:10.4161/org.6.1.11293 · Cited by 84
Acetylation of 53BP1 dictates the DNA double strand break repair pathway
Guo, X. Y., Bai, Y., Zhao, M., Zhou, M., Shen, Q., Yun, C., Zhang, H., Zhu, W., & Wang, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1208 · Cited by 67
Morales, J. L., & Perdew, G. H. (2006) · Biochemistry · doi:10.1021/bi062165b · Cited by 68
Systems-wide proteomic characterization of combinatorial post-translational modification patterns
Young, N. L., Plazas-Mayorca, M. D., & Garcia, B. A. (2010) · Expert Review of Proteomics · doi:10.1586/epr.09.100 · Cited by 71
Wu, C.-E., Esfandiari, A., Ho, Y.-H., Wang, N., Mahdi, A. K., Aptullahoglu, E., Lovat, P., & Lunec, J. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.433 · Cited by 61
De, U., Son, J. Y., Sachan, R., Park, Y. J., Kang, D., Yoon, K., Lee, B. M., Kim, I. S., Moon, H. R., & Kim, H. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092743 · Cited by 63
Modeling the regulation of p53 activation by HIF‐1 upon hypoxia
Wang, P., Guan, D., Zhang, X., Liu, F., & Wang, W. (2019) · FEBS Letters · doi:10.1002/1873-3468.13525 · Cited by 65
Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Shimizu, K., Gi, M., Suzuki, S., North, B. J., Watahiki, A., Fukumoto, S., Asara, J. M., Tokunaga, F., Wei, W., & Inuzuka, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109988 · Cited by 62
“For instance, acetylation is found to compete with ubiquitination at the same acceptor lysine residue, leading to stabilization of individual target proteins (Grönroos et al., 2002; Li et al., 2002,2012; Liu et al., 2014; Wang et al., 2017).”
Proteasomes from Structure to Function: Perspectives from Archaea
Maupin-furlow, J. A., Humbard, M. A., Kirkland, P. A., Li, W., Reuter, C. J., Wright, A. J., & Zhou, G. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75005-0 · Cited by 70
Huang, W.-Y., Yang, P., Chang, Y.-F., Márquez, V. E., & Chen, C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.014 · Cited by 65
Wang, H., Zhao, Y., Li, L., McNutt, M. A., Wu, L., Lu, S., Yu, Y., Zhou, W., Feng, J., Chai, G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702454200 · Cited by 69
A genetically encoded 19 F NMR probe for lysine acetylation
Zhang, F., Zhou, Q., Yang, G., An, L., Li, F., & Wang, J. (2018) · Chemical Communications · doi:10.1039/c7cc09825a · Cited by 62
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022) · Oncogene · doi:10.1038/s41388-022-02331-9 · Cited by 60
Self-citationDegradation of cyclin A is regulated by acetylation
Mateo, F., Vidal-Laliena, M., Canela, N., Busino, L., Martinez-Balbas, M. A., Pagano, M., Agell, N., & Bachs, O. (2009) · Oncogene · doi:10.1038/onc.2009.127 · Cited by 60
Yang, X., Wang, J., Liu, C., Grizzle, W. E., Yu, S., Zhang, S., Barnes, S., Koopman, W. J., Mountz, J. D., Kimberly, R. P., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62045-7 · Cited by 70
Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1
Lee, W.-Y., Lee, W.-T., Cheng, C.-H., Chen, K.-C., Chou, C.-M., Chung, C.-H., Sun, M.-S., Cheng, H.-W., Ho, M.-N., & Lin, C.-W. (2015) · Oncotarget · doi:10.18632/oncotarget.4768 · Cited by 58
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 64
Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6
Wood, M., Rymarchyk, S., Zheng, S. G., & Cen, Y. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.12.009 · Cited by 65
Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis
Huovinen, M., Loikkanen, J. J., Myllynen, P. K., & Vähäkangas, K. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.03.018 · Cited by 65
A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response
Chau, J. F. L., Jia, D., Wang, Z., Liu, Z., Hu, Y., Zhang, X., Jia, H., Lai, K. P., Leong, W. F., Au, B. J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1832 · Cited by 61
Metadata
- Authors
- Li, M., Luo, J., Brooks, C. L., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50607-50611
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082541302
- Cited by
- 503
- References
- 34
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 22 · 2016: 15 · 2015: 18 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6528 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (5-T32-CAO9503-17, T32CA009503)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 acetylation, MDM2, ubiquitination, p53 stabilization, post-translational modification, DNA damage response, tumor suppressor regulation, site competition
- MeSH terms
- Acetylation, Animals, Burkitt Lymphoma, Cloning, Molecular, DNA Damage, HeLa Cells, Humans, Kinetics, Neoplasm Proteins, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Recombinant Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Ubiquitin, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.